Skip to main content

Developed by Human Metabolomics Institute, Inc. and based on data from 6,000 clinical samples, the Liver Fibrosis and Cirrhosis Screening Kit features a groundbreaking non-invasive in-vitro diagnostic technology that assesses the levels of liver fibrosis and the early risk of liver cirrhosis through the detection and analysis of serological indicators repeatedly screened via metabolomics. The kit meets the high clinical standards and requirements for the sensitivity and specificity of test results, and can be used for repeated test with good stability of results. 

 

Liver Fibrosis and Cirrhosis Screening Kit 

The kit offers highly diagnostic accuracy for liver fibrosis, especially for early liver fibrosis, which is more convenient for dynamic monitoring of the disease progression and evaluation of efficacy. 

 

The kit has been passed the application for approval of innovative medical device by Guangdong Medical Products Administration and registered in U.S. Food and Drug Administration, with four invention patents, one international patent, and two software copyrights. 

Testing Procedure

01

Sample collection 

02

IVD kit processing 

03

Mass spectrometry detection 

04

Analysis by AI-enabled diagnostic software 

05

Issuance of a test report 

Sample Requirements 

Recommended sample volume 

Serum30µL

 

 

Sample Preservation

Please repack the samples collected in time and then store them in a - 80℃ refrigerator as soon as possible 15 minutes after the quenching of liquid nitrogen. Repeated freeze-thawing should be avoided.

 

 

Technical Advantages 

  • Wide applicationIt can be used to test serum, plasma, or dry blood spots. 
  • High compatibilityIt applies to many liquid chromatography-tandem mass spectrometry systems from different Chinese manufacturers. 
  • Superior qualityComprehensive and strict quality control measures lead to the reliability of test results. 
  • High throughputIt can automatically test multiple samples and analyze results, hence reducing human errors. 

  • High accuracyWith liver biopsy as the prime standard, both its sensitivity and specificity are above 90%. 

 

 

Contact Us